TY - JOUR
T1 - Adrenergic beta blockade and changes in plasma potassium following epinephrine administration
AU - Grassi, Angela O.
AU - de Lew, María F.
AU - Cingolani, Horacio E.
AU - Blesa, Enrique S.
PY - 1971/7
Y1 - 1971/7
N2 - Injection of epinephrine, 5 μg/kg in the dog produced, among other effects, two well known effects on metabolism: hyperglycemia and a transient hyperkalemia followed by hypokalemia. The effects were compared with those found in dogs pretreated with a beta adrenoceptor blocking agent. Our results show that after either 0.05 mg/kg or 0.5 mg/kg of d, 1-propranolol, hyperglycemia and hypokalemia to epinephrine were significantly changed. The early increase of serum potassium by epinephrine was reduced and delayed by the beta blocking agent; the hypokalemic effect was clearly prevented by the three doses of propranolol used (0.05, 0.5 and 2 mg/kg) suggesting a possible relation between the mechanism producing hypokalemia and the beta adrenoceptors blocked by propranolol.
AB - Injection of epinephrine, 5 μg/kg in the dog produced, among other effects, two well known effects on metabolism: hyperglycemia and a transient hyperkalemia followed by hypokalemia. The effects were compared with those found in dogs pretreated with a beta adrenoceptor blocking agent. Our results show that after either 0.05 mg/kg or 0.5 mg/kg of d, 1-propranolol, hyperglycemia and hypokalemia to epinephrine were significantly changed. The early increase of serum potassium by epinephrine was reduced and delayed by the beta blocking agent; the hypokalemic effect was clearly prevented by the three doses of propranolol used (0.05, 0.5 and 2 mg/kg) suggesting a possible relation between the mechanism producing hypokalemia and the beta adrenoceptors blocked by propranolol.
KW - Beta-receptors
KW - Catecholamines
KW - Plasma K concentration
KW - Potassium plasma concentration
KW - Propanolol
UR - http://www.scopus.com/inward/record.url?scp=0015088706&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0015088706&partnerID=8YFLogxK
U2 - 10.1016/0014-2999(71)90175-0
DO - 10.1016/0014-2999(71)90175-0
M3 - Article
C2 - 5153846
AN - SCOPUS:0015088706
SN - 0014-2999
VL - 15
SP - 209
EP - 213
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 2
ER -